Skip to main content Accessibility help
×
Home
Hostname: page-component-dc8c957cd-mn2s7 Total loading time: 0.352 Render date: 2022-01-28T05:32:13.348Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

8 - Prevention of infectious disease

Published online by Cambridge University Press:  05 June 2012

Rebecca Richards-Kortum
Affiliation:
Rice University, Houston
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stern, AM, Markel, H. The history of vaccines and immunization: familiar patterns, new challenges. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 611–21.CrossRefGoogle ScholarPubMed
,WHO. Mortality: Revised Global Burden of Disease (2002) Estimates. Geneva: World Health Organization; 2002.Google Scholar
Kasper, DL, Braunwald, E, Fauci, AS, Hauser, SL, Longo, DL, Jameson, JL, eds. Harrison's Principles of Internal Medicine. 16th edn. New York: McGraw-Hill; 2005.
Sompayrac, L. How Pathogenic Viruses Work. Sudbury, MA: Jones and Bartlett Publishers 2002.Google Scholar
,Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th edn. Washington DC: Public Health Foundation; 2007.Google Scholar
Sompayrac, L. How the Immune System Works. 2nd edn. Boulder Blackwell Publishing; 2003.Google Scholar
Silverthorn, DU. Human Physiology : an Integrated Approach. 3rd edn. San Francisco: Pearson/Benjamin Cummings; 2004.Google Scholar
,Centers for Disease Control and Prevention. 2004–05 U.S. Influenza Season Summary. Atlanta, GA; 2005 July 5.
,WHO Regional Office for the Eastern Mediterranean. Avian Influenza (Bird Flu): an Introduction. Division of Communicable Disease Control Newsletter. 2005 November (7).
Tumpey, TM, Basler, CF, Aguilar, PV, Zeng, H, Solorzano, A, Swayne, , et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (New York, NY). 2005 Oct 7; 310(5745): 77–80.CrossRefGoogle ScholarPubMed
Kobasa, D, Jones, SM, Shinya, K, Kash, JC, Copps, J, Ebihara, H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007 Jan 18; 445(7125): 319–23.CrossRefGoogle ScholarPubMed
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. 2007 April 11 [refd 2007 April 23]; Available from: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_04_11/en/print.html
,World Health Organization. Avian Influenza Frequently Asked Questions. 2005 December 5 [refd 2007 April 23]; Available from: http://www.who.int/csr/disease/avian_influenza/avian_faqs/en/index.html
Ulmer, JB, Valley, U, Rappuoli, R. Vaccine manufacturing: challenges and solutions. Nature Biotechnology. 2006 Nov; 24(11): 1377–83.CrossRefGoogle ScholarPubMed
Matthews, JT. Egg-based production of influenza vaccine: 30 years of commerical experience. The Bridge. 2006; 36(3): 17–24.Google Scholar
Langridge, WHR. Edible vaccines. Scientific American. 2000; 283(3): 66–71.CrossRefGoogle ScholarPubMed
Bloom, BR, Lambert, PH, eds. The Vaccine Book. San Diego: Academic Press; 2003.
Fenner, F, Henderson, DA, Arita, I, Jezek, Z, Ladnyi, ID. Smallpox and its Eradication. Geneva: World Health Organization; 1988.Google Scholar
Smith, KA. Medical immunology: a new journal for a new subspecialty. Medical Immunology. 2002 Sep 30; 1(1): 1.CrossRefGoogle ScholarPubMed
Abbas, AK, Lichtman, AH. Basic Immunology: Functions and Disorders of the Immune System. 2nd edn. Philadelphia: W.B. Saunders; 2004.Google Scholar
Mahmoud, A. The vaccine enterprise: time to act. Health Affairs. 2005; 24(3): 596–7.CrossRefGoogle Scholar
The infrastructure for vaccine development. Health Affairs. 2005; 24(3): 598.CrossRef
Levine, R. Millions Saved: Proven Successes in Global Health. Washington D.C.: Center for Global Development; 2004.Google Scholar
,Unicef. Immunization Summary 2006. New York: Unicef and WHO; 2006 January.Google Scholar
,Nurse Takes Plunge in Ebola Test. All Things Considered: National Public Radio; 2003.
Orenstein, WA, Douglas, RG, Rodewald, , Hinman, AR. Immunizations in the United States: success, structure, and stress. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 599–610.CrossRefGoogle Scholar
,Vaccine Education Center – Children's Hospital of Philadelphia. Frequently Asked Questions. 2003 [refd 2007 April 25]; Available from: http://www.chop.edu/consumer/jsp/division/generic.jsp?id=75743
,National Network for Immunization Information. Why Immunize? How Childhood Vaccines are Selected for Routine Use. 2004 [refd 2007 April 25]; Available from: http://www.immunizationinfo.org/parents/howVaccines_selected.cfm
,National Network for Immunization Information. Why Immunize? Monitoring Vaccine Safety. 2007 [refd 2007 April 25]; Available from: http://www.immunizationinfo.org/parents/monitoringSafety.cfm
,National Network for Immunization Information. Why Immunize? How Vaccines Work. 2007 [refd 2007 April 25]; Available from: http://www.immunizationinfo.org/parents/howVaccines_work.cfm
,Centers for Disease Control and Prevention. Diptheria epidemic – new independent states of the former Soviet Union, 1990–1994. Morbidity and Mortality Weekly Report. 1995; 44(10).Google Scholar
Colgrove, J, Bayer, R. Could it happen here? Vaccine risk controversies and the specter of derailment. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 729–39.CrossRefGoogle ScholarPubMed
Offit, PA. Why are pharmaceutical companies gradually abandoning vaccines?Health Affairs (Project Hope). 2005 May–Jun; 24(3): 622–30.CrossRefGoogle ScholarPubMed
Wakefield, AJ, Murch, SH, Anthony, A, Linnell, J, Casson, DM, Malik, M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. 1998 Feb 28; 351(9103): 637–41.CrossRefGoogle ScholarPubMed
,Centers for Disease Control and Prevention. Childhood & Adolescent Immunization Schedules 2007 [refd 2007 April 27]; Available from: http://www.cdc.gov/nip/recs/child-schedule.htm#presentation
Buckland, BC. The process development challenge for a new vaccine. Nature Medicine. 2005 Apr; 11(4 Suppl.): S16–19.CrossRefGoogle ScholarPubMed
Smith, NM, Bresee, JS, Shay, DK, Uyeki, TM, Cox, NJ, Strikas, RA. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 2006 July 28; 55(RR-10).Google Scholar
Scannon, PJ. Pharmaceutical preparedness for an epidemic. The Bridge. 2006; 36(3): 10–16.Google Scholar
,Centers for Disease Control and Prevention. Vaccine Storage and Handling Toolkit. 2005 June [refd 2007 April 30]; Available from: http://www2a.cdc.gov/nip/isd/shtoolkit/splash.html
Estell, D. Adapting industry practices for the rapid, large scale manufacture of pharmaceutical proteins. The Bridge. 2006; 36(3): 39–44.Google Scholar
Rappuoli, R. Cell culture based vaccine production: technological options. The Bridge. 2006; 36(3): 25–30.Google Scholar
Shaw, A. Alternative methods of making influenza vaccines. The Bridge. 2006; 36(3): 31–8.Google Scholar
Anderson, RM. Planning for pandemics of infectious diseases. The Bridge. 2006; 36(3): 5–9.Google Scholar
Clancy, C, Callaghan, M, Kelly, T. A multi-scale problem arising in a model of avian flu virus in a seabird colony. Journal of Physics: Conference Series. 2006; 55: 45–54.Google Scholar
Heuer, AH. Engineering and vaccine production for an influenza pandemic. The Bridge. 2006; 36(3): 3–4.Google Scholar
,Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington D.C.: National Academies Press; 2003.Google Scholar
McCluskey, MM, Alexander, SB, Larkin, BD, Murguia, M, Wakefield, S. An HIV vaccine: as we build it, will they come?Health Affairs (Project Hope). 2005 May–Jun; 24(3): 643–51.CrossRefGoogle ScholarPubMed
Vaccine Vial Monitors (VVMs). Seattle: PATH; 2005.
Safe Vaccine Handling, Cold Chain and Immunizations. Geneva: World Health Organization; 1998.
HealthTech Historical Profile: Technologies for Injection Safety. Seattle: PATH; 2006 January.
BD Immunization. 2007 [refd 2007 May 1]; Available from: http://www.bd.com/aboutbd/global/immunization.asp
Levine, MM. Can needle-free administration of vaccines become the norm in global immunization? Nature Medicine. 2003 Jan; 9(1): 99–103.CrossRefGoogle ScholarPubMed
GAVI Alliance Progress Report. 2007; Available from: http://www.gavialliance.org/media_centre/publications/index.php
Beal, J, Orrick, J, Alfonso, K, Rathore, M, eds. HIV/AIDS Primary Care Guide: Florida/Caribbean AIDS Education Training Center; 2006.Google Scholar
,Centers for Disease Control and Prevention. Frequently Asked Questions About HIV and HIV Testing [refd 2007 May 3]; Available from: http://www.hivtest.org/subindex.cfm?FuseAction=FAQ#1
Chou, R, Huffman, LH, Fu, R, Smits, AK, Korthuis, PT. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2005 Jul 5; 143(1): 55–73.CrossRefGoogle ScholarPubMed
Smith, KA. The HIV vaccine saga. Medical Immunology. 2003 Feb 14; 2(1): 1.CrossRefGoogle ScholarPubMed
Baltimore, D, Heilman, C. HIV vaccines: prospects and challenges. Scientific American. 1998 July; 279(1): 98–103.CrossRefGoogle ScholarPubMed
Letvin, NL. Progress and obstacles in the development of an AIDS vaccine. Nature Reviews. 2006 Dec; 6(12): 930–9.Google ScholarPubMed
Nowak, MA, McMichael, AJ. How HIV defeats the immune system. HIV: 20 Years of Research: Scientific American; 2003.Google Scholar
Carmichael, M. How it began: HIV before the age of AIDS. PBS Frontline. 2006 May 30.Google Scholar
Ezzel, C. Hope in a Vial. HIV: 20 Years of Research: Scientific American 2003: 38–43.Google Scholar
Singh, M. No vaccine against HIV yet – are we not perfectly equipped?Virology Journal. 2006; 3: 60.CrossRefGoogle Scholar
Eaton, L. AIDS vaccine may offer hope only for some ethnic groups. BMJ (Clinical research edn. 2003 Mar 1; 326(7387): 463.CrossRefGoogle ScholarPubMed
,AIDS vaccine only limited success. BBC News. 2003 February 24.
Kresge, KJ. VRC starts Phase II vaccine trial. VAX. 2005 October; 3(+++++10).Google Scholar

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×